Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Non-cash Items (2023 - 2025)

Beta Bionics (BBNX) has disclosed Non-cash Items for 3 consecutive years, with $141.9 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 518.98% to $141.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $141.9 million through Dec 2025, up 518.98% year-over-year, with the annual reading at $141.9 million for FY2025, 518.98% up from the prior year.
  • Non-cash Items hit $141.9 million in Q4 2025 for Beta Bionics, up from $3.5 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $141.9 million in Q4 2025 to a low of $535000.0 in Q4 2023.
  • Historically, Non-cash Items has averaged $43.2 million across 3 years, with a median of $33.4 million in 2024.
  • Biggest five-year swings in Non-cash Items: surged 4185.79% in 2024 and later surged 518.98% in 2025.
  • Year by year, Non-cash Items stood at $535000.0 in 2023, then soared by 4185.79% to $22.9 million in 2024, then soared by 518.98% to $141.9 million in 2025.
  • Business Quant data shows Non-cash Items for BBNX at $141.9 million in Q4 2025, $3.5 million in Q3 2025, and $43.8 million in Q2 2025.